Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $3.78M | ﹤0.01% |
9,710
+673
| +7% | +$337K |
|
4227
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $3.78M | ﹤0.01% |
136,109
-151,528
| -53% | -$4.59M |
|
4228
Global X Silver Miners ETF NEW
SIL
$4.79B
| $3.77M | ﹤0.01% |
145,748
+62,784
| +76% | +$2.01M |
|
4229
CALL
Ashland
ASH
$3.38B
| $3.77M | ﹤0.01% |
36,600
+2,100
| +6% | +$215K |
|
4230
PUT
Northern Trust
NTRS
$35B
| $3.77M | ﹤0.01% |
39,100
-4,700
| -11% | -$497K |
|
4231
PUT
Levi Strauss
LEVI
$8.68B
| $3.77M | ﹤0.01% |
231,000
-93,300
| -29% | -$1.68M |
|
4232
Invesco BulletShares 2029 High Yield Corporate Bond ETF
BSJT
$578M
| $3.77M | ﹤0.01% |
189,150
-148
| -0.1% | -$3.14K |
|
4233
Magna International
MGA
$18.8B
| $3.77M | ﹤0.01% |
68,637
+33,376
| +95% | +$2.03M |
|
|
PVLA
4234
Palvella Therapeutics
PVLA
$2.25B
| $3.77M | ﹤0.01% |
25,176
-849
| -3% | -$155K |
|
4235
Madrigal Pharmaceuticals
MDGL
$11.7B
| $3.77M | ﹤0.01% |
52,587
-6,865
| -12% | -$505K |
|
4236
PUT
Beam Therapeutics
BEAM
$2.76B
| $3.76M | ﹤0.01% |
97,200
+22,800
| +31% | +$906K |
|
4237
Gran Tierra Energy
GTE
$325M
| $3.76M | ﹤0.01% |
327,256
+182,491
| +126% | +$2.91M |
|
4238
First American
FAF
$7.54B
| $3.76M | ﹤0.01% |
71,082
+40,556
| +133% | +$2.36M |
|
4239
PUT
iQIYI
IQ
$1.3B
| $3.76M | ﹤0.01% |
895,800
-231,000
| -21% | -$930K |
|
|
ACII
4240
DELISTED
Atlas Crest Investment Corp. II
ACII
| $3.76M | ﹤0.01% |
383,487
-495,723
| -56% | -$4.86M |
|
4241
PUT
Genco Shipping & Trading
GNK
$1.15B
| $3.76M | ﹤0.01% |
194,500
-54,000
| -22% | -$1.22M |
|
4242
Barings BDC
BBDC
$975M
| $3.75M | ﹤0.01% |
403,139
+64,721
| +19% | +$657K |
|
4243
PUT
Zions Bancorporation
ZION
$10.5B
| $3.75M | ﹤0.01% |
73,700
+12,500
| +20% | +$710K |
|
4244
CALL
West Pharmaceutical
WST
$24.6B
| $3.75M | ﹤0.01% |
12,400
-11,200
| -47% | -$3.64M |
|
4245
CALL
JPMorgan BetaBuilders Europe ETF
BBEU
$9.52B
| $3.75M | ﹤0.01% |
+81,300
| New | +$4.14M |
|
4246
CALL
Itaú Unibanco
ITUB
$81.6B
| $3.75M | ﹤0.01% |
991,715
-164,738
| -14% | -$732K |
|
4247
PUT
FTI Consulting
FCN
$4.19B
| $3.74M | ﹤0.01% |
20,700
+19,100
| +1,194% | +$3.15M |
|
4248
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$39.1M
| $3.74M | ﹤0.01% |
19,377
-53,149
| -73% | -$9.66M |
|
4249
PUT
dLocal
DLO
$4.17B
| $3.74M | ﹤0.01% |
+142,400
| New | +$3.65M |
|
4250
PUT
Global X Uranium ETF
URA
$6.27B
| $3.73M | ﹤0.01% |
201,200
-154,900
| -43% | -$3.49M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.